Prediction and prevention of chemotherapy-induced cardiomyopathy - Can it be done?

被引：23

作者：

Granger, Christopher B. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA

来源：

CIRCULATION | 2006年 / 114卷 / 23期

关键词：

editorials; cardiomyopathy; prevention; trials; angiotensin;

D O I：

10.1161/CIRCULATIONAHA.106.666248

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2432 / 2433

页数：2

共 20 条

[11] Five cases of anthracycline-induced cardiomyopathy effectively treated with carvedilol [J].

Mukai, Y ;

Yoshida, T ;

Nakaike, R ;

Mukai, N ;

Iwato, K ;

Kyo, T ;

Kaseda, S .

INTERNAL MEDICINE, 2004, 43 (11) :1087-1088

[12] Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression [J].

Neilan, TG ;

Jassal, DS ;

Scully, MF ;

Chen, G ;

Deflandre, C ;

McAllister, H ;

Kay, E ;

Austin, SC ;

Halpern, EF ;

Harmey, JH ;

Fitzgerald, DJ .

EUROPEAN HEART JOURNAL, 2006, 27 (10) :1251-1256

[13]

NICKLAS JM, 1992, NEW ENGL J MED, V327, P685

[14] Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer [J].

Nuver, J ;

Smit, AJ ;

van der Meer, J ;

van den Berg, MP ;

van der Graaf, WTA ;

Meinardi, MT ;

Sleijfer, DT ;

Hoekstra, HJ ;

van Gessel, AI ;

van Roon, AM ;

Gietema, JA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9130-9137

[15] Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines [J].

Silber, JH ;

Cnaan, A ;

Clark, BJ ;

Paridon, SM ;

Chin, AJ ;

Rychik, J ;

Hogarty, AN ;

Cohen, MI ;

Barber, G ;

Rutkowski, M ;

Kimball, TR ;

Delaat, C ;

Steinherz, LJ ;

Zhao, HQ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :820-828

[16] Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats [J].

Soga, Mayako ;

Kamal, Fadia A. ;

Watanabe, Kenichi ;

Ma, Meilei ;

Palaniyandi, Suresh ;

Prakash, Paras ;

Veeraveedu, Punniyakoti ;

Mito, Sayaka ;

Kunisaki, Megumi ;

Tachikawa, Hitoshi ;

Kodama, Makoto ;

Aizawa, Yoshifusa .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (03) :378-385

[17] Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31 [J].

Tan-Chiu, E ;

Yothers, G ;

Romond, E ;

Geyer, CE ;

Ewer, M ;

Keefe, D ;

Shannon, RP ;

Swain, SM ;

Brown, A ;

Fehrenbacher, L ;

Vogel, VG ;

Seay, TE ;

Rastogi, P ;

Mamounas, EP ;

Wolmark, N ;

Bryant, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7811-7819

[18] Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy [J].

van Dalen, E. C. ;

van der Pal, H. J. H. ;

Caron, H. N. ;

Kremer, L. C. M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)

[19] Different anthracycline derivates for reducing cardiotoxicity in cancer patients (Withdrawn Paper, art. no. CD005006, 2006) [J].

van Dalen, E. C. ;

Michiels, E. M. C. ;

Caron, H. N. ;

Kremer, L. C. M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04)

[20]

WONTERS KA, 2005, BRIT J HAEMATOL, V131, P561

← 1 2 →